Compare LAB & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAB | NPCE |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 354.1M | 432.3M |
| IPO Year | 2008 | 2021 |
| Metric | LAB | NPCE |
|---|---|---|
| Price | $0.93 | $15.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $1.35 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 2.6M | 165.9K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.54 | 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $101,937,000.00 | $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | $2.63 | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $0.87 | $7.56 |
| 52 Week High | $1.72 | $18.97 |
| Indicator | LAB | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 62.07 |
| Support Level | $0.92 | $15.25 |
| Resistance Level | $1.01 | $15.71 |
| Average True Range (ATR) | 0.05 | 0.67 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 48.54 | 91.26 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.